WithdrawnPhase 2

Cryoablation Versus Radiofrequency Ablation for Small Renal Masses

Stopped: Cryoablation is no longer offered at our hospital, and likely won't be offered in the near future.

Canada0Started 2010-03

Plain-language summary

The purpose of this study is to verify the oncological efficacy and safety of cryoablation and radiofrequency ablation for the treatment of small renal tumors.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with tumors that progress in size while on a watchful waiting protocol; * Patients with multiple tumors; * Patients with a tumor in a solitary kidney; * Patients with poor renal function and a renal tumor; * Patients with significant co-morbidities that may benefit from a less invasive approach. Exclusion Criteria: * Large tumors \> 4.0cm; * Unable to have a general anesthetic; * Unable to comply with follow-up protocol (i.e., routine CT or MRI and a follow-up biopsy); * Uncorrectable bleeding diathesis; * Evidence of metastatic disease.

What they're measuring

Treatment failure rate.

Timeframe: Baseline, Weeks 6, 12, 24, 36, 48

Trial details

NCT IDNCT00922948

SponsorSt. Joseph's Healthcare Hamilton

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-03

View on ClinicalTrials.gov More Renal Cancers trials